An inhalable medicine with the potential to improve lung disease in people with cystic fibrosis, irrespective of their mutation type, is being tested in human trials in the UK and Europe.
Pneumonia is an infection of the lungs that can be caused most commonly by bacteria or viruses, such as Streptococcus ...
A discovery offers new hope in the battle against pulmonary fibrosis, a debilitating lung condition that progressively makes it harder for patients to breathe. Scientists have pinpointed proteins in ...
19h
A discovery at Duke-NUS Medical School offers new hope in the battle against pulmonary fibrosis, a debilitating lung ...
A groundbreaking study led by researchers at Insilico Medicine has revealed the potential of TNIK inhibition as an innovative ...
Researchers from the European Molecular Biology Laboratory have found that dextromethorphan, a common cough syrup ingredient, ...
An international team of researchers has, for the first time, created a detailed map of the location and identity of individual cells in the adult lung, both from healthy lungs and in lungs from ...
The Broad Institute and Illumina today announced their intent to collaborate on a groundbreaking Spatial Flagship Project, ...
Columnist Ann Reynoso, who's now preparing for a bilateral lung transplant, is counting on her strength and perseverance to ...
Vatican authorities said Monday that Pope Francis is suffering from a “polymicrobial respiratory tract infection.” Experts talk about what that means.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback